section name header

Pronunciation

si-proe-HEP-ta-deen

Classifications

Therapeutic Classification: allergy, cold and cough remedies, antihistamines

Indications

BEERS REMS


Unlabeled Use:
  • Stimulation of appetite.

Action

  • Antagonizes the effects of histamine at H1-receptor sites; does not bind to or inactivate histamine.
  • Also blocks the effects of serotonin, which may result in increased appetite.
Therapeutic effects:
  • Decreased symptoms of histamine excess (sneezing, rhinorrhea, nasal and ocular pruritus, ocular tearing and redness).
  • Decreased cold urticaria.

Pharmacokinetics

Absorption: Well absorbed following oral administration.

Distribution: Unknown.

Metabolism/Excretion: Mostly metabolized by the liver.

Half-Life: Unknown.

Time/Action Profile

(antihistaminic effects)

ROUTEONSETPEAKDURATION
PO15–60 min1–2 hr8 hr





Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: arrhythmias, hypotension, palpitations

Derm: photosensitivity, rash

EENT: blurred vision

GI: dry mouth, constipation

GU: urinary hesitancy, urinary retention

Metab: weight gain

Neuro: drowsiness, excitation (increased in children)

Interactions

Drug-drug:

Route/Dosage

Availability

(Generic available)

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Periactin